Ares Serono, average Swiss pharmaceutical company, is a world leader in fertility drugs. The company has successfully become one of the few biotechnology companies in Europe. The case is considered a core set of strategic and organizational challenges facing the new director. "Hide
by Mikhail Y. Yoshino, Jean-Pierre Jeannet, Carin-Isabel Knoop Source: Harvard Business School 43 pages. Publication Date: September 8, 1995. Prod. #: 396035-PDF-ENG
Related Case Solutions & Analyses:
Block 16: Conocos Green Oil Strategy (C)
Executone Information Systems Inc.
General Dynamics and Computer Sciences Corp.: Outsourcing the IS Function (A)
MediMedia International Ltd.
Signalling Costs
Hong Kong: A Concise Profile, 2014
Opening the Valve: From Software to Hardware (B)
Elasto Therm: The Next Step
Genpact Inc. – Business Process Outsourcing to India
Wanxiang Group: A Chinese Company’s Global Strategy, Portuguese Version
